Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Jently vs Mochi Health

Jently
Graded #170

Higher grade

vs+14.700000000000003
Mochi Health
Graded #480

Lower grade

The verdict

Jently takes it — 67/100 to 52.3/100.

Jently grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Jently is a clinician-guided telehealth service offering compounded GLP-1 weight management (semaglutide from $149/mo, tirzepatide from $199/mo) alongside NAD+, peptide therapy (sermorelin, glutathione),…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueJently +29
74
45
Dose & formulationJently +24
64
40
Clinical oversightJently +8
79
71
Labs & monitoringEven
52
52
FulfillmentJently +2
67
65
Contract termsJently +10
51
41
Jently · left barMochi Health · right bar

The numbers

MetricJentlyMochi Health
WeighScore67/10052.3/100
GradeCC
Scorecard rank#170#480
Semaglutide$149/mo (starting dose, compounded)Not disclosed
Tirzepatide$199/mo (starting dose, compounded)Not disclosed
CoverageCoverage not published15 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Jently

Graded #170 · C

Strengths

  • Compounded semaglutide from $149/mo and tirzepatide from $199/mo — pricing published
  • Multi-pillar: GLP-1, NAD+, peptides (sermorelin, glutathione), and metformin
  • 100% online with licensed providers via the MD Integrations network
  • Subscription can be cancelled anytime through the patient portal

Where it loses points

  • Specific pharmacy partner not named on the site
  • No refunds once a consultation is completed or a prescription is dispensed
  • Not LegitScript-certified (no certification displayed)
  • States of operation not published
Mochi Health

Graded #480 · C

Strengths

  • Aggressively low monthly pricing
  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

Where it loses points

  • Limited public information on program details

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard